shortagewatch

Home / Blood / Icatibant

ATC B06AC02 · Other Hematological Agents

Icatibant shortage

As of 31 Oct 2026, Icatibant has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 6 products.

Countries3/5
Products6packs or presentations
Short since24 Mar 20267 months ago
Earliest return29 Nov 2026company estimate
No return date3products
Main reasonIncreased demand

Timeline

ItalySpainAustria
2027ICATIBANT ACCORDICATIBANT ACCORDICATIBANT PIRAMALICATIBANT PIRAMALICATIBANT TEVAICATIBANT TEVAICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG , 1 jeringa precargada + 1 agujaICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa precargada de 3 ml + agujaIcatibant ratiopharm 30 mg Injektionslösung Icatibant ratiopharm 30 mg Injektionslösung in einer Fertigspritze, 1 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITICATIBANT ACCORDACCORD HEALTHCARE, S.L.U.24 Mar 2026not givenIncreased demand
Elevata richiesta
ITICATIBANT PIRAMALPIRAMAL CRITICAL CARE ITALIA S.P.A.11 May 2026not givenIncreased demand
Elevata richiesta
ITICATIBANT TEVATEVA B.V.12 Oct 202615 Feb 2027Manufacturing problem
Problemi produttivi
ESICATIBANTO CIPLA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG , 1 jeringa precargada + 1 agujaCipla Europe N.V.21 Jun 202629 Nov 2026Not stated
ESICATIBANTO GLENMARK 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa precargada de 3 ml + agujaGlenmark Arzneimittel Gmbh6 Oct 202614 Dec 2026Not stated
ATIcatibant ratiopharm 30 mg Injektionslösung in einer Fertigspritze, 1 StückTeva B.V.12 Oct 2026not givenDistribution or logistics
Verzögerung bei der Auslieferung

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.